Frederic Kontny

3.5k total citations · 1 hit paper
49 papers, 1.9k citations indexed

About

Frederic Kontny is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Immunology. According to data from OpenAlex, Frederic Kontny has authored 49 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Cardiology and Cardiovascular Medicine, 18 papers in Surgery and 9 papers in Immunology. Recurrent topics in Frederic Kontny's work include Acute Myocardial Infarction Research (21 papers), Antiplatelet Therapy and Cardiovascular Diseases (11 papers) and Coronary Interventions and Diagnostics (10 papers). Frederic Kontny is often cited by papers focused on Acute Myocardial Infarction Research (21 papers), Antiplatelet Therapy and Cardiovascular Diseases (11 papers) and Coronary Interventions and Diagnostics (10 papers). Frederic Kontny collaborates with scholars based in Norway, Sweden and United Kingdom. Frederic Kontny's co-authors include Lars Wallentin, Steen Husted, Eva Swahn, Bo Lagerqvist, Robert F. Storey, Stefan James, Richard C. Becker, Ulrich Abildgaard, Jon Dale and Philippe Gabríel Steg and has published in prestigious journals such as The Lancet, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Frederic Kontny

49 papers receiving 1.8k citations

Hit Papers

Comparison of ticagrelor with clopidogrel in patients wit... 2010 2026 2015 2020 2010 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frederic Kontny Norway 17 1.6k 895 421 330 127 49 1.9k
Mattía Galli Italy 22 1.4k 0.9× 689 0.8× 240 0.6× 296 0.9× 149 1.2× 138 1.9k
George Kassimis Greece 19 1.3k 0.8× 853 1.0× 288 0.7× 210 0.6× 147 1.2× 110 1.6k
Anthony J. Dalby United States 19 2.2k 1.4× 1.1k 1.2× 256 0.6× 511 1.5× 295 2.3× 34 2.6k
Antonio Montinaro Italy 12 1.1k 0.7× 909 1.0× 286 0.7× 230 0.7× 44 0.3× 22 1.5k
Adam Witkowski Poland 18 1.2k 0.7× 570 0.6× 364 0.9× 364 1.1× 54 0.4× 128 1.6k
Fabio Mangiacapra Italy 29 2.1k 1.3× 1.7k 1.9× 1.1k 2.6× 280 0.8× 163 1.3× 122 2.8k
Annunziata Nusca Italy 18 1.1k 0.7× 954 1.1× 339 0.8× 128 0.4× 295 2.3× 102 2.0k
Jinqing Yuan China 18 954 0.6× 681 0.8× 262 0.6× 103 0.3× 213 1.7× 177 1.4k
Berrin Umman Türkiye 19 798 0.5× 373 0.4× 346 0.8× 107 0.3× 51 0.4× 71 1.1k
Ralph Vicari United States 6 1.5k 1.0× 1.1k 1.2× 727 1.7× 149 0.5× 227 1.8× 16 2.0k

Countries citing papers authored by Frederic Kontny

Since Specialization
Citations

This map shows the geographic impact of Frederic Kontny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederic Kontny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederic Kontny more than expected).

Fields of papers citing papers by Frederic Kontny

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederic Kontny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederic Kontny. The network helps show where Frederic Kontny may publish in the future.

Co-authorship network of co-authors of Frederic Kontny

This figure shows the co-authorship network connecting the top 25 collaborators of Frederic Kontny. A scholar is included among the top collaborators of Frederic Kontny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frederic Kontny. Frederic Kontny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ueland, Thor, Pål Aukrust, Dennis W Nilsen, et al.. (2023). Procollagen type 1 N-terminal propeptide is associated with adverse outcome in acute chest pain of suspected coronary origin. Frontiers in Cardiovascular Medicine. 10. 1191055–1191055. 3 indexed citations
2.
Ueland, Thor, Axel Åkerblom, Tatevik Ghukasyan Lakic, et al.. (2019). ALCAM predicts future cardiovascular death in acute coronary syndromes: Insights from the PLATO trial. Atherosclerosis. 293. 35–41. 4 indexed citations
3.
Andersen, Thomas T., Lars Wallentin, Axel Åkerblom, et al.. (2019). CXC MOTIF LIGAND 16: A NOVEL, INDEPENDENT PREDICTOR OF CARDIOVASCULAR DEATH AND MORBIDITY IN ACUTE CORONARY SYNDROMES - A SUBSTUDY OF THE PLATELET INHIBITION AND PATIENT OUTCOMES TRIAL. Journal of the American College of Cardiology. 73(9). 71–71. 1 indexed citations
5.
Wallentin, Lars, Annika E. Michelsen, Pål Aukrust, et al.. (2015). ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE (ALCAM) AND OUTCOMES IN ACUTE CORONARY SYNDROMES: A PLATO BIOMARKER SUBSTUDY. Journal of the American College of Cardiology. 65(10). A231–A231. 1 indexed citations
6.
Kontny, Frederic, et al.. (2010). Effects of telmisartan on office and 24-hour ambulatory blood pressure: an observational study in hypertensive patients managed in primary care. SHILAP Revista de lepidopterología. 1 indexed citations
7.
Cannon, Christopher P., Robert A. Harrington, Stefan James, et al.. (2010). Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study. The Lancet. 375(9711). 283–293. 436 indexed citations breakdown →
8.
Pönitz, Volker, Harry Staines, Heidi Grundt, et al.. (2009). The long pentraxin 3 (PTX3): a novel prognostic inflammatory marker for mortality in acute chest pain. Thrombosis and Haemostasis. 102(9). 555–563. 26 indexed citations
9.
Jacobsen, Michael Dilou, Galen S. Wagner, Lene Holmvang, et al.. (2004). Quantitative T-wave analysis predicts 1 year prognosis and benefit from early invasive treatment in the FRISC II study population. European Heart Journal. 26(2). 112–118. 17 indexed citations
10.
Olesen, Mette Linnet, Elizabeth Kwong, Frederic Kontny, et al.. (2002). No Effect of Cyclooxygenase Inhibition on Plaque Size in Atherosclerosis-prone Mice. Scandinavian Cardiovascular Journal. 36(6). 362–367. 45 indexed citations
11.
Lagerqvist, Bo, et al.. (2001). Better outcome after 2 years with an early invasive strategy in unstable coronary artery disease (UCAD) - FRISCII 2 year follow-up.. Circulation. 104(17). 2589. 2 indexed citations
12.
Kontny, Frederic. (2001). Improving outcomes in acute coronary syndromes-The FRISCII trial. Clinical Cardiology. 24(S1). 3–7. 11 indexed citations
13.
Chesebro, James H., Freek W.A. Verheugt, Frederic Kontny, et al.. (2001). Evaluating the place of low-molecular-weight heparin in the management of acute coronary syndromes. Clinical Cardiology. 24(S1). 20–22. 1 indexed citations
14.
Dellborg, Mikael, et al.. (2000). Reduced thiamine phosphate, but not thiamine diphosphate, in erythrocytes in elderly patients with congestive heart failure treated with furosemide. Journal of Internal Medicine. 247(5). 597–600. 21 indexed citations
15.
Kontny, Frederic, et al.. (2000). Lipoprotein(a), Other Lipoproteins and Hemostatic Profiles in Patients with Ischemic Stroke: The Relation to Cardiogenic Embolism. Cerebrovascular Diseases. 10(2). 110–117. 25 indexed citations
16.
Kontny, Frederic. (2000). Acute management-How should we intervene?. Clinical Cardiology. 23(S1). 8–12. 3 indexed citations
17.
Pedersen, Terje R., et al.. (2000). Benefits of early lipid-lowering intervention in high-risk patients: The lipid intervention strategies for coronary patients study. Clinical Therapeutics. 22(8). 949–960. 8 indexed citations
18.
Pedersen, Terje R., et al.. (1999). Lipid intervention strategies in acute coronary syndromes: A randomised trial with simvastatin. Atherosclerosis. 144. 198–198. 3 indexed citations
20.
Kontny, Frederic, et al.. (1996). Low molecular weight heparin (Fragmin®) in acute myocardial infarction. Journal of the American College of Cardiology. 27(2). 166–166. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026